These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27084038)

  • 1. The role of innate immunity in the immunopathology and treatment of HBV infection.
    Maini MK; Gehring AJ
    J Hepatol; 2016 Apr; 64(1 Suppl):S60-S70. PubMed ID: 27084038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity and HBV persistence.
    Chiale C; Marchese AM; Robek MD
    Curr Opin Virol; 2021 Aug; 49():13-20. PubMed ID: 33992859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
    Khanam A; Chua JV; Kottilil S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Curative Immunomodulation Strategies for Chronic Hepatitis B Virus Infection.
    Zhu W; Liu H; Zhang X
    ACS Infect Dis; 2019 May; 5(5):703-712. PubMed ID: 30907080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY; Yang Y; Zhou G; Tu ZK
    World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.
    Jiang X; Kanda T; Wu S; Nakamura M; Miyamura T; Nakamoto S; Banerjee A; Yokosuka O
    World J Gastroenterol; 2014 Jun; 20(23):7197-206. PubMed ID: 24966589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive immunity in HBV infection.
    Bertoletti A; Ferrari C
    J Hepatol; 2016 Apr; 64(1 Suppl):S71-S83. PubMed ID: 27084039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.
    Bertoletti A; Ferrari C
    Gut; 2012 Dec; 61(12):1754-64. PubMed ID: 22157327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S; Altstetter SM; Protzer U
    World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of HBV immune evasion.
    Kuipery A; Gehring AJ; Isogawa M
    Antiviral Res; 2020 Jul; 179():104816. PubMed ID: 32387476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
    Koh S; Bertoletti A
    Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
    Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK
    J Hepatol; 2013 Feb; 58(2):225-33. PubMed ID: 23046671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunology of hepatitis B.
    Vierling JM
    Clin Liver Dis; 2007 Nov; 11(4):727-59, vii-viii. PubMed ID: 17981227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune responses in hepatitis B virus (HBV) infection.
    Busca A; Kumar A
    Virol J; 2014 Feb; 11():22. PubMed ID: 24507433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
    Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
    Front Immunol; 2022; 13():965018. PubMed ID: 35967443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of Hepatitis B Virus.
    Tseng TC; Huang LR
    J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.